Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018 provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Overview
- 3 Products under Development
- 3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
- 3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
- 3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
- 3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
- 3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
- 3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials
- 4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products under Development by Companies
- 4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development
- 4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
- 5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies and Product Overview
- 5.1 3DT Holdings LLC Company Overview
- 5.2 Aachen Resonance GmbH Company Overview
- 5.3 Acrostak (Schweiz) AG Company Overview
- 5.4 AlviMedica Medical Technologies Inc. Company Overview
- 5.5 Andramed GmbH Company Overview
- 5.6 Atrium Medical Corp Company Overview
- 5.7 Bolton Medical Inc Company Overview
- 5.8 Boston Scientific Corp Company Overview
- 5.9 BrosMed Medical Co., Ltd Company Overview
- 5.10 Cordis Corp Company Overview
- 5.11 CorNova Inc Company Overview
- 5.12 Hatch Medical LLC Company Overview
- 5.13 Innovia LLC Company Overview
- 5.14 iVascular SLU Company Overview
- 5.15 Kaneka Corp Company Overview
- 5.16 Lithotech Medical Ltd Company Overview
- 5.17 Medtronic plc Company Overview
- 5.18 Meril Life Sciences Pvt Ltd Company Overview
- 5.19 MicroPort Scientific Corp Company Overview
- 5.20 Natec Medical Ltd Company Overview
- 5.21 QT Vascular Ltd Company Overview
- 5.22 QualiMed Innovative Medizinprodukte GmbH Company Overview
- 5.23 Sahajanand Medical Technologies Pvt Ltd Company Overview
- 5.24 Spectranetics Corp Company Overview
- 5.25 Terumo Interventional Systems Company Overview
- 5.26 VasoTech Inc. Company Overview
- 6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters- Recent Developments
- 6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
- 6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
- 6.3 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
- 6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
- 6.5 May 10, 2018: Neovasc Announces Results for the First Quarter 2018
- 6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
- 6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
- 6.8 Apr 26, 2018: Getinge publishes Interim Report for January-March 2018
- 6.9 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
- 6.10 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
- 6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
- 6.12 Mar 29, 2018: Foxtrot NC PTCA Gains Regulatory Approval in Malaysia
- 6.13 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
- 6.14 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
- 6.15 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
- 6.16 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
- 6.17 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program
- 6.18 Feb 08, 2018: MicroPort Endovascular Hercules Series Products Gain Regulatory Approval in Colombia
- 6.19 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
- 6.20 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology
- 6.21 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
- 6.22 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
- 6.23 Jan 30, 2018: United Health Products Issues Update on HemoStyp South Korea MFDS Application
- 6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
- 6.25 Jan 29, 2018: Getinge Reported Net Sales Of SEK22,495 M In 2017
- 6.26 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices
- 6.27 Jan 25, 2018: Firefighter, Foxtrot Pro, and Foxtrot NC Gain Regulatory Approval in India
- 6.28 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
- 6.29 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer
- 6.30 Jan 09, 2018: MicroPort Selected as 2017 China Innovative Medical Device Company
- 6.31 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation
- 6.32 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
- 7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
- 1.1 List of Tables
- Table 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
- Table 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
- Table 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
- Table 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
- Table 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
- Table 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials
- Table 7: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development
- Table 8: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
- Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 10: Conductance Balloon Coronary Post-Dilatation Catheter - Product Status
- Table 11: Conductance Balloon Coronary Post-Dilatation Catheter - Product Description
- Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 13: VIAR - Product Status
- Table 14: VIAR - Product Description
- Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
- Table 16: PTCA Balloon - Product Status
- Table 17: PTCA Balloon - Product Description
- Table 18: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 19: ProHP - Product Status
- Table 20: ProHP - Product Description
- Table 21: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 22: Zero-Profile PTCA Balloon - Product Status
- Table 23: Zero-Profile PTCA Balloon - Product Description
- Table 24: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 25: Coronary Stent Balloon Catheter - Product Status
- Table 26: Coronary Stent Balloon Catheter - Product Description
- Table 27: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 28: Flash PTCA - Product Status
- Table 29: Flash PTCA - Product Description
- Table 30: Runner PTCA Balloon Catheter - Product Status
- Table 31: Runner PTCA Balloon Catheter - Product Description
- Table 32: Runner Slim PTCA - Product Status
- Table 33: Runner Slim PTCA - Product Description
- Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 35: 1.2 Zulu PTCA - Product Status
- Table 36: 1.2 Zulu PTCA - Product Description
- Table 37: NC Zulu PTCA Post-Dilatation Catheter - Product Status
- Table 38: NC Zulu PTCA Post-Dilatation Catheter - Product Description
- Table 39: Next Generation PCB - Product Status
- Table 40: Next Generation PCB - Product Description
- Table 41: Zulu PTCA Pre-Dilatation Catheter - Product Status
- Table 42: Zulu PTCA Pre-Dilatation Catheter - Product Description
- Table 43: Boston Scientific Corp - Ongoing Clinical Trials Overview
- Table 44: Next Generation PCB - Cutting Balloon Versus High Pressure Balloon for the Treatment of AV Graft Stenosis
- Table 45: BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 46: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Status
- Table 47: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Description
- Table 48: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Status
- Table 49: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Description
- Table 50: BrosMed Medical Co., Ltd - Ongoing Clinical Trials Overview
- Table 51: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-Dilatation of Stenosis and Occlusion in Patients With Symptomatic Ischemic Heart Disease
- Table 52: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-Dilatation of Stenosis and Occlusion in Patients With Symptomatic Ischemic Heart Disease
- Table 53: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 54: Next Generation EMPIRA PTCA Balloon - Product Status
- Table 55: Next Generation EMPIRA PTCA Balloon - Product Description
- Table 56: CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview
- Table 57: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status
- Table 58: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description
- Table 59: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status
- Table 60: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description
- Table 61: FiberHalo SRM Stent Delivery Catheter - Product Status
- Table 62: FiberHalo SRM Stent Delivery Catheter - Product Description
- Table 63: Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 64: Hydra Bifurcated Coronary Balloon Catheter - Product Status
- Table 65: Hydra Bifurcated Coronary Balloon Catheter - Product Description
- Table 66: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
- Table 67: Low Profile Angioplasty Balloon Catheter - Product Status
- Table 68: Low Profile Angioplasty Balloon Catheter - Product Description
- Table 69: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview
- Table 70: Scoring Balloon - Product Status
- Table 71: Scoring Balloon - Product Description
- Table 72: Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 73: Ikazuchi Zero - Product Status
- Table 74: Ikazuchi Zero - Product Description
- Table 75: Raiden 3 - Product Status
- Table 76: Raiden 3 - Product Description
- Table 77: Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 78: Scoring Balloon - Product Status
- Table 79: Scoring Balloon - Product Description
- Table 80: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
- Table 81: Euphora Drug Coated Balloon - Product Status
- Table 82: Euphora Drug Coated Balloon - Product Description
- Table 83: Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 84: MeRes100 - Product Status
- Table 85: MeRes100 - Product Description
- Table 86: Meril Life Sciences Pvt Ltd - Ongoing Clinical Trials Overview
- Table 87: MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend)
- Table 88: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 89: Hercules-D - Product Status
- Table 90: Hercules-D - Product Description
- Table 91: Ryfle PTCA Balloon - Product Status
- Table 92: Ryfle PTCA Balloon - Product Description
- Table 93: Ryfle PTCA Balloon Catheter - Product Status
- Table 94: Ryfle PTCA Balloon Catheter - Product Description
- Table 95: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 96: NATEC Angioplasty Balloon - Product Status
- Table 97: NATEC Angioplasty Balloon - Product Description
- Table 98: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 99: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status
- Table 100: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description
- Table 101: Silk PTCA Balloon Catheter - Product Status
- Table 102: Silk PTCA Balloon Catheter - Product Description
- Table 103: QT Vascular Ltd - Ongoing Clinical Trials Overview
- Table 104: Chocolate Touch PTCA Coronary Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon
- Table 105: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Table 106: Biodegradable Balloon - Product Status
- Table 107: Biodegradable Balloon - Product Description
- Table 108: Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Table 109: Advanced Balloon Catheter - Product Status
- Table 110: Advanced Balloon Catheter - Product Description
- Table 111: Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
- Table 112: CardioSculpt Valvuloplasty Scoring Balloon - Product Status
- Table 113: CardioSculpt Valvuloplasty Scoring Balloon - Product Description
- Table 114: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
- Table 115: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
- Table 116: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
- Table 117: PTCA Balloon - Product Status
- Table 118: PTCA Balloon - Product Description
- Table 119: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Table 120: DirectBalloon - Product Status
- Table 121: DirectBalloon - Product Description
- Table 122: Glossary
- 1.2 List of Figures
- Figure 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
- Figure 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
- Figure 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
- Figure 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
- Figure 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
- Figure 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
